Clinical trial / 2021
One week of nicotinamide riboside supplementation does not alter whole-body metabolism or skeletal muscle mitochondrial signaling in response to exercise.
Eight male participants received 1000 mg/day of nicotinamide riboside (NR) or cellulose placebo for 1 week to evaluate metabolic and skeletal muscle responses to a 1-hour cycling bout. NR supplementation had no effect on substrate utilization at rest or during exercise, nor on skeletal muscle mitochondrial respiration. It also did not alter skeletal muscle NAD+ concentration, global acetylation, auto-PARylation of PARP1, or acetylation of p53 Lys382 and MnSOD Lys122. However, NR increased concentrations of deaminated NAD+ precursors (NAR and NAM) and methylated breakdown products (Me2PY and Me4PY).
- Study type
- Supplementation trial
- Who was studied
- 8 male participants (age: 23 ± 4 years, VO2peak 46.5 ± 4.4 ml kg-1 min-1)
- What was measured
- Substrate utilization, skeletal muscle mitochondrial respiration, NAD+ metabolome, and mitochondrial biogenic signaling pathways
THE PAPER
Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic responses to a single bout of endurance exercise.
Stocks B, Ashcroft SP, Joanisse S, Dansereau LC, Koay YC, Elhassan YS, Lavery GG, Quek LE, O'Sullivan JF, Philp AM, Wallis GA, Philp A. J Physiol, 2021.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.